Phase 2 Hypersensitivity Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels
Food Hypersensitivity
Johns Hopkins University32 enrolled1 locationNCT06934200
Recruiting
Phase 2
Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
antibiotic allergyDrug hypersensitivityCephalosporin Allergy+4 more
Massachusetts General Hospital300 enrolled6 locationsNCT06406114
Recruiting
Phase 1Phase 2
Novel Biomarkers of Non-IgE Immediate Hypersensitivity Drug Reactions
Healthy VolunteerVancomycinHypersensitivity Reactions
Johns Hopkins University25 enrolled1 locationNCT07605806
Recruiting
Phase 2
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Progressive Pulmonary FibrosisInterstitial Lung DiseasePulmonary Fibrosis+7 more
Avalyn Pharma Inc.375 enrolled152 locationsNCT06329401
Recruiting
Phase 2
Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients
Food allergyPeanut allergyFood Allergy Peanut+3 more
Rima Rachid37 enrolled1 locationNCT05695261
Not Yet Recruiting
Phase 2
A pilot study of corticosteroid and antihistamine premedication to prevent hypersensitivity reactions in patients receiving second (or subsequent) line treatment with Carboplatin for treatment of gynaecological malignancy
hypersensitivity reactions in patients receiving carboplatin for gynaecological malignancy
The Royal Women's Hospital46 enrolled2 locationsACTRN12613000646741